Kaushlendra Kumar

410 total citations
8 papers, 344 citations indexed

About

Kaushlendra Kumar is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Kaushlendra Kumar has authored 8 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Kaushlendra Kumar's work include Inhalation and Respiratory Drug Delivery (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Kaushlendra Kumar is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Kaushlendra Kumar collaborates with scholars based in India. Kaushlendra Kumar's co-authors include Amit Misra, Awadh Bihari Yadav, Jatinder Kaur, Rolee Sharma, Pavan Muttil, Rahul Kumar Verma, Ravi Shankar Prasad Singh, Priya Ranjan Prasad Verma, Jatinder Kaur Mukker and Dinesh K. Dikshit and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, European Journal of Medicinal Chemistry and Molecular Pharmaceutics.

In The Last Decade

Kaushlendra Kumar

8 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaushlendra Kumar India 6 233 129 90 75 47 8 344
Ayca Yıldız-Peköz Türkiye 13 125 0.5× 144 1.1× 41 0.5× 56 0.7× 97 2.1× 23 460
Kohei Togami Japan 14 261 1.1× 66 0.5× 93 1.0× 19 0.3× 88 1.9× 43 473
Ashlee D. Brunaugh United States 12 203 0.9× 166 1.3× 26 0.3× 48 0.6× 113 2.4× 16 420
Chia‐Chen Lin Taiwan 6 81 0.3× 74 0.6× 27 0.3× 111 1.5× 42 0.9× 25 319
Kwame N. Atuah United Kingdom 6 123 0.5× 158 1.2× 23 0.3× 24 0.3× 131 2.8× 7 370
Mradul Mohan India 9 103 0.4× 52 0.4× 63 0.7× 97 1.3× 22 0.5× 18 290
Sadhna Sharma India 7 59 0.3× 140 1.1× 37 0.4× 47 0.6× 106 2.3× 18 299
Priya Muralidharan United States 9 335 1.4× 153 1.2× 22 0.2× 26 0.3× 59 1.3× 16 440
Mohammad Farazuddin United States 9 43 0.2× 32 0.2× 44 0.5× 45 0.6× 71 1.5× 18 270
María José de Jesús Valle Spain 10 71 0.3× 63 0.5× 23 0.3× 39 0.5× 66 1.4× 21 345

Countries citing papers authored by Kaushlendra Kumar

Since Specialization
Citations

This map shows the geographic impact of Kaushlendra Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaushlendra Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaushlendra Kumar more than expected).

Fields of papers citing papers by Kaushlendra Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaushlendra Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaushlendra Kumar. The network helps show where Kaushlendra Kumar may publish in the future.

Co-authorship network of co-authors of Kaushlendra Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Kaushlendra Kumar. A scholar is included among the top collaborators of Kaushlendra Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaushlendra Kumar. Kaushlendra Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kumar, Kaushlendra, et al.. (2024). Assessment of Land Suitability for Coconut Cultivation in Southern Karnataka, India. Asian Journal of Soil Science and Plant Nutrition. 10(1). 420–428. 1 indexed citations
2.
Kumar, Kaushlendra, et al.. (2016). Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids. European Journal of Medicinal Chemistry. 110. 1–12. 10 indexed citations
3.
Chandasana, Hardik, et al.. (2015). Pharmacokinetics and tissue distribution study of novel potent antiplatelet agent S007-867 in mice using HPLC-MS/MS. Xenobiotica. 45(6). 530–537. 4 indexed citations
4.
Kumar, Kaushlendra, Stuti Srivastava, Manish Jain, et al.. (2014). Synthesis and identification of chiral aminomethylpiperidine carboxamides as inhibitor of collagen induced platelet activation. European Journal of Medicinal Chemistry. 81. 456–472. 13 indexed citations
5.
Verma, Rahul Kumar, Jatinder Kaur Mukker, Ravi Shankar Prasad Singh, et al.. (2012). Partial Biodistribution and Pharmacokinetics of Isoniazid and Rifabutin Following Pulmonary Delivery of Inhalable Microparticles to Rhesus Macaques. Molecular Pharmaceutics. 9(4). 1011–1016. 25 indexed citations
6.
Kaur, Jatinder, Pavan Muttil, Rahul Kumar Verma, et al.. (2008). A hand-held apparatus for “nose-only” exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages. European Journal of Pharmaceutical Sciences. 34(1). 56–65. 64 indexed citations
7.
Verma, Rahul Kumar, Jatinder Kaur, Kaushlendra Kumar, Awadh Bihari Yadav, & Amit Misra. (2008). Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice. Antimicrobial Agents and Chemotherapy. 52(9). 3195–3201. 83 indexed citations
8.
Muttil, Pavan, Jatinder Kaur, Kaushlendra Kumar, et al.. (2007). Inhalable microparticles containing large payload of anti-tuberculosis drugs. European Journal of Pharmaceutical Sciences. 32(2). 140–150. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026